Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23803,977,1.18 [1.07-1.30],0.0010462144755319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23721,191,1.33 [1.08-1.65],0.0072525505313422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25693,185,1.10 [0.88-1.38],0.4123914004563408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18151,752,1.27 [1.13-1.42],5.16385214648642e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25628,120,0.87 [0.65-1.17],0.3611528965015046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24586,83,1.17 [0.84-1.64],0.3515547665923156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27045,119,0.86 [0.64-1.15],0.3061048982657849
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27039,80,0.83 [0.58-1.19],0.3080587963006455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23965,66,1.56 [1.12-2.17],0.0087687046436232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26386,119,1.22 [0.93-1.61],0.1490513301060401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26337,70,1.26 [0.88-1.80],0.1990897589583492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27122,78,1.36 [0.98-1.87],0.065392007020915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27090,101,1.33 [0.99-1.77],0.0549699121778046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27086,97,1.32 [0.98-1.77],0.0681289303770919
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,26753,63,1.22 [0.84-1.77],0.300699451541397
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25937,431,1.24 [1.08-1.44],0.0030520274534037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25636,130,1.28 [0.99-1.66],0.0631458757982448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25803,297,1.30 [1.10-1.55],0.0023100288906524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22200,48,0.58 [0.35-0.96],0.0332721962197405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22216,64,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22400,248,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22407,255,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22811,659,0.88 [0.77-1.00],0.0499195688228844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22203,51,1.30 [0.87-1.95],0.1991199563526535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24329,1018,1.01 [0.92-1.12],0.7917798415430728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26076,278,0.98 [0.81-1.19],0.849934201301473
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,26794,101,0.98 [0.71-1.33],0.8776686254481567
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27220,86,1.02 [0.73-1.44],0.8913459224355866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,27004,55,1.25 [0.84-1.85],0.2739772214254425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27216,71,0.97 [0.67-1.42],0.8895880227013654
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Stomach,27263,56,0.99 [0.65-1.52],0.970136416848296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,27037,272,1.06 [0.88-1.28],0.5272577319697183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27211,108,1.23 [0.92-1.63],0.159372866936475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27210,104,0.94 [0.69-1.29],0.7116996593622732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27143,70,0.70 [0.47-1.05],0.0867513763045901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",27145,69,0.73 [0.49-1.10],0.129315313502232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,27054,266,1.07 [0.88-1.30],0.4836747841572802
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27221,120,1.17 [0.89-1.55],0.2627814510135842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,27111,229,1.19 [0.97-1.45],0.0941662822580031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of breast,27201,135,0.87 [0.65-1.15],0.312901212099388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,26697,995,0.97 [0.88-1.08],0.6169127766523769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,25870,266,1.15 [0.95-1.39],0.1473481816606569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25606,444,1.09 [0.94-1.27],0.2496765528025404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25606,444,1.09 [0.94-1.27],0.2496765528025404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24082,409,1.26 [1.08-1.46],0.0024220704441471
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26703,94,0.58 [0.41-0.83],0.0027322587504606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,26913,108,1.67 [1.29-2.15],7.763931779163419e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22626,913,1.37 [1.24-1.52],1.5730725357486184e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24963,889,1.18 [1.06-1.30],0.0022162944964042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25432,121,1.31 [1.00-1.71],0.0468221951633423
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26263,60,1.80 [1.30-2.48],0.0003398466319184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25418,107,1.39 [1.05-1.83],0.0207292822648806
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,25720,409,1.75 [1.52-2.01],2.894544203546188e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,25710,399,1.75 [1.52-2.01],4.586075942183215e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25196,197,1.40 [1.11-1.76],0.0041022803587917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25199,194,1.40 [1.11-1.76],0.0042717602254408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22438,725,1.34 [1.19-1.50],6.089025927214314e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21797,84,1.37 [1.00-1.88],0.051953733592005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22384,671,1.35 [1.20-1.52],5.617115868780516e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21762,49,1.74 [1.21-2.50],0.0030406765999513
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21781,68,1.46 [1.04-2.05],0.0276355852455744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,22975,612,1.29 [1.14-1.46],3.908855082866064e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22478,115,1.23 [0.92-1.62],0.1575956380954113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27027,77,1.08 [0.76-1.54],0.6550309073247755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27065,45,1.19 [0.76-1.86],0.4420355024664373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25827,37,0.92 [0.55-1.56],0.7612735261889434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27216,37,0.86 [0.51-1.45],0.5666985556961256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22400,37,0.94 [0.56-1.59],0.8168122103925117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Alcohol dependence,25813,23,1.05 [0.55-2.00],0.8751498989590003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,25706,34,1.34 [0.82-2.20],0.2496098113867687
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22406,43,1.32 [0.84-2.06],0.2239269466950091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22744,381,1.28 [1.10-1.50],0.0015494772951187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression,25272,337,1.26 [1.07-1.48],0.0064815099878073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,22527,296,1.33 [1.12-1.58],0.0012447876775707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22508,145,1.43 [1.13-1.81],0.00319355256448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Other anxiety disorders,25351,72,1.11 [0.78-1.59],0.5613181100038604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,23490,1614,1.15 [1.06-1.24],0.0007500768014098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21475,175,1.38 [1.10-1.72],0.0044147636318008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27067,147,1.31 [1.03-1.66],0.0293477885498354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,25948,418,1.01 [0.86-1.18],0.9229497798174632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,25666,136,0.84 [0.63-1.10],0.2074106222527644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,25656,126,1.39 [1.08-1.79],0.010070629398656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",26834,116,1.39 [1.07-1.81],0.0136630124877688
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26573,60,1.25 [0.85-1.83],0.2511958337771908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,25624,94,0.98 [0.70-1.36],0.8918270384311311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,26852,67,0.96 [0.65-1.42],0.8536312238475918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",25896,854,1.14 [1.02-1.27],0.0162233383616855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25163,121,1.10 [0.83-1.46],0.5035003125767978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25585,543,1.11 [0.97-1.27],0.1155742692525133
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27005,75,1.18 [0.84-1.68],0.3387092209066822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,26987,57,1.10 [0.73-1.65],0.6474372279886424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,26776,121,1.03 [0.77-1.37],0.8407618746246801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26530,421,1.14 [0.98-1.33],0.0789419427785955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26357,248,1.24 [1.03-1.50],0.0235935718126797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26181,72,1.16 [0.81-1.65],0.4270634974195442
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26244,135,1.33 [1.04-1.70],0.0249715672163254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26214,105,1.17 [0.87-1.57],0.2895070782745559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23167,179,1.23 [0.98-1.54],0.0705853127298967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23390,402,1.08 [0.92-1.26],0.3706423906859797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26236,185,1.04 [0.83-1.31],0.7245454201244563
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26997,35,1.16 [0.70-1.94],0.5591791708008162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1762,35,0.76 [0.43-1.35],0.3507884057099516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25270,35,1.23 [0.74-2.03],0.425200609451861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26565,94,1.29 [0.96-1.74],0.0969866483882131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26524,53,1.37 [0.93-2.02],0.116741337222251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26433,96,1.25 [0.93-1.70],0.1385920407508588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26696,105,0.92 [0.67-1.26],0.6192193585137118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27139,128,1.46 [1.14-1.87],0.0026127161753481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26474,106,1.21 [0.90-1.62],0.1998878800922885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20073,2767,1.19 [1.11-1.27],9.70673938272656e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26689,72,0.99 [0.68-1.44],0.9630872592425722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21085,2045,1.20 [1.11-1.30],2.6094934375821988e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,21107,2067,1.20 [1.12-1.30],1.4796613374874787e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19088,48,1.65 [1.13-2.42],0.0104002135320747
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25598,720,1.32 [1.18-1.48],1.3773045658137836e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,25377,499,1.26 [1.10-1.44],0.0009019029831682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26599,145,1.33 [1.04-1.69],0.0213165775010303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26679,225,1.46 [1.21-1.76],7.684006408888968e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27194,28,1.67 [1.02-2.71],0.0398284956758638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24975,97,1.58 [1.21-2.08],0.0009056868565769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25347,481,1.34 [1.17-1.53],2.816682652263072e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26476,99,1.19 [0.88-1.61],0.2650805354604677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26575,216,1.15 [0.94-1.42],0.1772817507895657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26471,94,0.89 [0.64-1.25],0.5099517059976056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26471,94,0.89 [0.64-1.25],0.5099517059976056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19131,91,0.94 [0.67-1.31],0.7070565018022964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23689,38,1.37 [0.86-2.17],0.181061811450078
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,23729,78,1.19 [0.85-1.68],0.3042064640418163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16377,101,0.95 [0.69-1.31],0.7539445011846784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16547,271,1.12 [0.92-1.35],0.2661063219114975
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,23702,51,1.47 [1.00-2.17],0.0479786650987238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23707,56,0.54 [0.34-0.86],0.0089658972392324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26425,98,1.37 [1.02-1.83],0.0344153636962828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26488,129,1.21 [0.93-1.58],0.1571094990319028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26529,97,1.15 [0.84-1.56],0.391006915909811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26598,85,1.24 [0.90-1.71],0.1946123845439675
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26284,68,1.25 [0.87-1.78],0.2271797731836113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26327,111,1.43 [1.10-1.86],0.0080118187991208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25662,131,1.14 [0.87-1.50],0.3291190766002692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25636,105,1.16 [0.86-1.56],0.3434891281690011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27052,102,1.16 [0.86-1.57],0.3298508224541153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,26125,594,0.97 [0.85-1.11],0.6671207674030233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,26127,90,1.34 [0.99-1.81],0.0576604143989588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22142,2076,1.17 [1.09-1.26],1.976662573878775e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27048,127,1.20 [0.92-1.57],0.1762177368448019
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25635,195,1.29 [1.05-1.59],0.015703881848038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25616,176,1.32 [1.07-1.65],0.0114824163281266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26362,228,0.96 [0.78-1.18],0.6814304966108643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26354,220,0.96 [0.77-1.19],0.7062945939247628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26495,553,1.17 [1.03-1.33],0.0180371588901728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,26056,114,1.04 [0.78-1.40],0.7689901571748087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,26021,79,1.24 [0.89-1.73],0.2050823575760427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26291,349,1.23 [1.05-1.45],0.0105511216418414
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,26081,139,1.16 [0.89-1.50],0.2720916736329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13116,62,1.38 [0.95-2.00],0.0881515766655177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24335,1152,1.13 [1.03-1.25],0.0080109181214564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,26210,156,1.32 [1.04-1.67],0.0203543126292483
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26230,176,1.21 [0.96-1.51],0.1072095046478411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26230,176,1.21 [0.96-1.51],0.1072095046478411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25229,991,1.10 [1.00-1.22],0.0602382378395194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,20235,991,1.16 [1.05-1.29],0.0034844728085525
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20046,991,1.17 [1.05-1.29],0.0031806500354248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20220,976,1.15 [1.03-1.27],0.0093185276988861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26939,85,1.26 [0.91-1.73],0.1625347097886612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,25491,64,1.25 [0.87-1.81],0.2335415268469272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27015,64,1.25 [0.87-1.81],0.2290100191139925
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25484,57,1.24 [0.84-1.83],0.2767815978555032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,25430,85,1.05 [0.75-1.48],0.7693904556206859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,25531,186,1.12 [0.89-1.40],0.3398877714556321
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26097,89,1.08 [0.78-1.50],0.6420308542434159
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18871,5937,1.18 [1.13-1.25],6.694774773072517e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26704,465,1.11 [0.97-1.29],0.1394365875443619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27220,100,1.00 [0.73-1.37],0.9951292377702488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,27225,90,1.08 [0.78-1.51],0.6299570731677675
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,26343,104,1.41 [1.07-1.86],0.0162530245082794
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26358,119,0.98 [0.73-1.30],0.8690382246178987
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27212,111,1.03 [0.76-1.39],0.8604115223953307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26352,113,1.08 [0.81-1.44],0.6050557198215645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26052,78,1.23 [0.88-1.72],0.2286309076609027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27124,49,1.35 [0.90-2.03],0.141855145261564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20593,219,1.07 [0.87-1.32],0.5287902543779862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22678,2304,1.14 [1.07-1.22],0.0001175270233341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,20663,289,1.29 [1.09-1.54],0.0035312487511756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21105,731,1.23 [1.10-1.38],0.0002737148009461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20451,77,1.24 [0.89-1.73],0.2074150238621863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20506,132,1.45 [1.14-1.84],0.0026350228411013
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20412,38,1.01 [0.61-1.69],0.9663359836024076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,20518,144,1.00 [0.77-1.30],0.9833782586475932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,20450,76,1.09 [0.77-1.55],0.6221397070067765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27173,54,0.97 [0.63-1.49],0.8890391852124687
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,20508,134,1.15 [0.89-1.50],0.2814140306514492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21209,835,1.12 [1.00-1.25],0.0454931025101197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,27094,143,1.20 [0.93-1.54],0.1567752140223888
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,20953,579,1.02 [0.89-1.16],0.8095090403756566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20551,177,1.26 [1.01-1.57],0.038430183439733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27131,139,1.13 [0.87-1.47],0.3440729601142519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,27065,114,1.15 [0.87-1.54],0.3262158350587442
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,24380,1186,1.10 [1.00-1.21],0.0433259859133269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,23262,68,0.73 [0.48-1.09],0.1234485624930528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,23264,70,1.15 [0.80-1.65],0.4555690763096977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,23299,105,0.96 [0.70-1.31],0.8030824048907085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24145,951,1.15 [1.04-1.28],0.0069722565745357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26182,904,1.16 [1.04-1.28],0.0056733156118079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,21566,2152,1.11 [1.04-1.19],0.0034957055230996
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26916,60,1.35 [0.94-1.94],0.1084983138014726
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27187,85,1.17 [0.84-1.62],0.3450555327978418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,25363,85,1.18 [0.85-1.64],0.3195417105681375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25339,61,1.09 [0.73-1.61],0.6828602993178514
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27114,128,0.94 [0.71-1.25],0.6753613721807263
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,25406,128,0.95 [0.72-1.26],0.7245499665775119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25392,114,0.99 [0.73-1.33],0.9393128539384412
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26050,772,1.21 [1.08-1.35],0.0007038006306792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26039,761,1.21 [1.08-1.35],0.0006834403971298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19518,104,1.23 [0.92-1.64],0.1698955404264323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal stricture,26790,104,1.21 [0.90-1.62],0.2013928436603694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19478,64,0.99 [0.67-1.46],0.9583276674529244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20077,663,1.16 [1.02-1.31],0.0184902784101118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19652,238,1.33 [1.11-1.61],0.0026525609209732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19805,391,1.16 [1.00-1.36],0.0552448890055714
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,25566,348,1.14 [0.97-1.35],0.1179215161368304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,26748,123,1.49 [1.16-1.91],0.0019385163421324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19536,122,1.24 [0.95-1.62],0.1201939606334603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19459,45,0.76 [0.47-1.24],0.266817811560513
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20284,870,1.02 [0.92-1.14],0.6647555106604279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,19644,230,1.02 [0.83-1.26],0.8435034123635403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26730,105,1.54 [1.18-2.01],0.0016228782994278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,26474,103,1.06 [0.78-1.45],0.6926236954081426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,26422,51,1.06 [0.69-1.64],0.7857400233124778
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25700,871,1.25 [1.13-1.39],2.5414136180236085e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,25558,729,1.28 [1.14-1.43],1.900921088047309e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,24958,129,1.35 [1.05-1.75],0.0205759025432833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24898,69,1.12 [0.77-1.62],0.54928499392199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,24889,60,1.47 [1.02-2.11],0.036696131629764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27101,60,1.45 [1.01-2.08],0.0465129585914296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,25880,308,1.43 [1.22-1.68],1.0452824004466117e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25676,104,1.51 [1.16-1.96],0.002031670377593
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,25660,88,1.64 [1.25-2.15],0.0003097536394379
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25613,41,1.57 [1.03-2.38],0.0346736539765548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,25740,168,1.43 [1.15-1.77],0.0011963284135653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,25730,158,1.38 [1.10-1.72],0.0056348092392191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24127,1599,1.04 [0.96-1.13],0.3809744381936126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,26801,109,1.08 [0.80-1.45],0.6119332980639572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26804,453,1.09 [0.94-1.26],0.2735440228601389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25703,693,1.01 [0.90-1.14],0.8204261727891371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26443,316,1.06 [0.89-1.26],0.5349499496691248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26196,69,1.09 [0.76-1.58],0.6327880939197265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26327,200,1.07 [0.85-1.33],0.5764021937219512
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,26967,88,1.18 [0.85-1.62],0.3209686742133065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26941,62,1.13 [0.77-1.66],0.5347880019829759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26927,48,1.13 [0.73-1.75],0.5875527992972241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26987,54,1.31 [0.88-1.94],0.1775847987435937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26984,51,1.26 [0.84-1.90],0.267733916115486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26407,56,1.30 [0.88-1.92],0.1876888074297886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26708,357,1.03 [0.87-1.21],0.7464182241532035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25113,103,0.94 [0.68-1.29],0.6878280412616505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25163,153,0.93 [0.72-1.21],0.5859940998004245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25122,112,0.92 [0.68-1.25],0.6108917714277098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25264,254,1.06 [0.87-1.29],0.5383835411120026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25238,228,1.05 [0.86-1.29],0.6271184437930056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19197,4366,1.09 [1.03-1.15],0.002598889830161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20926,2511,1.08 [1.01-1.16],0.029635258082848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24468,1330,1.16 [1.06-1.26],0.0007932691633402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18624,209,1.19 [0.96-1.47],0.1077523213827713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18934,519,1.21 [1.05-1.38],0.0070154113710132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26682,200,1.19 [0.96-1.47],0.1134901404098203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26701,185,1.23 [0.99-1.53],0.0586407505551803
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19634,1219,1.14 [1.03-1.25],0.0091890288803054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22308,1219,1.13 [1.03-1.24],0.0105858611218011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18428,13,1.49 [0.67-3.33],0.3277926208597986
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27058,13,1.39 [0.62-3.11],0.4285541022232682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18696,281,1.23 [1.02-1.47],0.027167087738928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18503,88,1.12 [0.80-1.56],0.5048920025625416
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18720,305,1.02 [0.84-1.22],0.8747178717263183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27061,155,1.00 [0.78-1.29],0.9945979101396484
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18895,480,1.14 [0.99-1.32],0.0743320449804087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18900,485,1.20 [1.04-1.39],0.0108713293320823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19820,1405,1.03 [0.95-1.13],0.4615546183198067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18522,107,1.04 [0.76-1.41],0.8121556080718536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18835,420,0.93 [0.80-1.10],0.4111944207210879
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18497,82,0.73 [0.50-1.07],0.1041437364164327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18516,101,0.83 [0.59-1.15],0.2627442911298832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18781,366,1.14 [0.97-1.34],0.1095357812616385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18725,310,1.22 [1.02-1.45],0.0268296412130708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20295,297,1.16 [0.97-1.38],0.1155796808595011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26448,219,0.77 [0.61-0.96],0.0220779081582668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26322,93,1.30 [0.96-1.75],0.0928202860196897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23310,81,1.03 [0.73-1.47],0.8500972189691035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23531,302,1.04 [0.87-1.25],0.6563008204678038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24250,1021,1.11 [1.00-1.22],0.0472557669603805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23441,212,1.02 [0.82-1.27],0.8682167382152256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23306,77,1.13 [0.79-1.60],0.5040236827043718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24045,816,1.13 [1.01-1.26],0.0262854833784275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23280,51,1.05 [0.68-1.63],0.8178942201645826
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23475,246,1.12 [0.92-1.37],0.2497611260678048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23331,102,1.04 [0.77-1.42],0.7852943820873282
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23320,91,1.16 [0.84-1.59],0.3694099850485588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23392,163,1.12 [0.88-1.43],0.3563068160758593
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23304,75,1.32 [0.94-1.85],0.1059350405926723
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23580,351,1.14 [0.96-1.34],0.12743470995367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23520,382,1.11 [0.95-1.30],0.2000795790023175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23208,70,0.85 [0.57-1.25],0.4021606744601799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23249,111,1.12 [0.83-1.50],0.4648441535644885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23281,143,1.17 [0.90-1.51],0.2325468508676307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23175,37,0.96 [0.57-1.63],0.8889990131915917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23196,58,0.94 [0.62-1.44],0.7921572919544597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23180,42,0.81 [0.48-1.35],0.4091888896751736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23415,277,1.25 [1.04-1.49],0.017368693377151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23196,58,1.33 [0.90-1.95],0.1503555833809418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23207,69,0.94 [0.64-1.38],0.7467340375807747
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23276,138,1.38 [1.08-1.77],0.0092746506383971
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23219,81,0.88 [0.61-1.26],0.4789847759892904
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23676,538,1.15 [1.00-1.31],0.0450688397483091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23331,193,0.98 [0.78-1.23],0.8399609627734533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23428,290,1.12 [0.93-1.34],0.2398892877694437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24527,235,1.15 [0.94-1.41],0.169633724648309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24774,482,1.05 [0.91-1.21],0.5021347935173839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24332,40,1.07 [0.65-1.75],0.7946861829857983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24356,64,0.97 [0.65-1.45],0.8819058519483691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24406,114,1.05 [0.78-1.41],0.7347121405034105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22231,6060,1.06 [1.01-1.11],0.0138717703771151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24814,199,1.23 [1.00-1.52],0.0544703837256996
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24659,44,1.03 [0.64-1.66],0.8928296457674646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24983,36,1.38 [0.85-2.22],0.1922125326727201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,24994,47,1.52 [1.01-2.27],0.0429686515428454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24989,42,1.30 [0.83-2.05],0.2486883851743409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27012,130,1.04 [0.79-1.37],0.793093132535093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,26891,63,1.39 [0.98-1.98],0.0646540601031627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26980,98,0.96 [0.70-1.33],0.8157840017631449
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26917,35,1.17 [0.70-1.96],0.5549379474155076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25058,1236,1.12 [1.03-1.23],0.0109122064885162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,23957,135,1.25 [0.97-1.61],0.0895576208312943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23905,83,1.28 [0.93-1.77],0.1345510032561942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,23988,166,1.30 [1.04-1.63],0.0233206474371722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23910,88,1.18 [0.86-1.63],0.3098968480343297
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,24795,973,1.15 [1.04-1.27],0.0064368346014554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26940,475,0.87 [0.75-1.02],0.0801609723160661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26613,148,0.72 [0.54-0.94],0.0177734335349775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26633,168,0.89 [0.69-1.14],0.3434455016852068
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26575,110,1.07 [0.79-1.43],0.6747513336018008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26876,550,1.12 [0.98-1.27],0.1047781466884018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26459,133,0.99 [0.75-1.30],0.9244826531016788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26573,247,1.28 [1.06-1.54],0.0114620396797867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24820,4531,1.04 [0.99-1.10],0.1260105920602941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,20650,361,1.20 [1.02-1.41],0.0301010362228034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20388,99,1.22 [0.90-1.66],0.1946706168513373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20454,165,1.12 [0.88-1.43],0.3569493386825023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21063,774,1.08 [0.96-1.21],0.2088175024376324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20691,402,0.98 [0.84-1.15],0.8331791609823317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21231,942,0.98 [0.88-1.09],0.6546963235649604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20602,313,0.84 [0.70-1.01],0.0678233900218913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20725,436,1.05 [0.90-1.22],0.5283614012692915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20387,98,1.01 [0.73-1.39],0.9640034146254612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20475,186,1.03 [0.82-1.30],0.7874026167498845
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27217,266,1.08 [0.89-1.30],0.4560049617763539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27228,252,1.08 [0.89-1.31],0.4374113746507114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27253,138,1.08 [0.83-1.40],0.5759539796973376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27243,152,1.09 [0.85-1.40],0.5094615914864329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20431,142,1.09 [0.84-1.41],0.5282855070162111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20402,113,0.86 [0.63-1.17],0.3352394314264257
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20425,136,1.45 [1.14-1.84],0.0026497023080132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Irregular menses,27147,464,1.04 [0.89-1.20],0.6389866969893063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21623,1334,0.99 [0.90-1.08],0.7616064051041072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21162,873,0.96 [0.85-1.07],0.4222293028308206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27233,194,0.95 [0.76-1.20],0.6686790197195966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20742,453,0.95 [0.82-1.11],0.5509011153808514
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20611,322,1.08 [0.91-1.29],0.3695210991071911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21180,891,0.99 [0.89-1.11],0.9272760993626106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female infertility,20403,114,1.21 [0.90-1.61],0.1996998878136364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20396,107,1.21 [0.90-1.63],0.2059069453303361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27250,862,1.02 [0.91-1.15],0.7220020934898548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27256,1182,0.98 [0.88-1.09],0.7434483943149721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27250,469,1.05 [0.90-1.22],0.5099082827530581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26918,137,1.00 [0.76-1.31],0.990330240954468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26965,184,1.07 [0.85-1.36],0.5626283006501036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26945,164,1.19 [0.93-1.51],0.1674792968132032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27270,167,0.94 [0.73-1.22],0.6579188018038562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27272,164,0.91 [0.70-1.18],0.4872170942170494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27267,410,1.05 [0.89-1.23],0.56836527234807
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26981,124,0.93 [0.69-1.25],0.6289992427535225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27084,227,1.10 [0.88-1.36],0.4011986019492818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26532,144,1.36 [1.05-1.75],0.0180379634847393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26585,197,1.03 [0.81-1.30],0.8321178291138245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26633,245,0.97 [0.79-1.21],0.8020193089117938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26534,146,0.85 [0.64-1.13],0.2549677819415595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26523,135,0.99 [0.75-1.32],0.958187772756426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26536,148,0.73 [0.55-0.97],0.0327970550168466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26304,230,0.91 [0.73-1.13],0.3903965964147645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26502,428,1.00 [0.85-1.18],0.9581577298035828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26733,659,0.98 [0.85-1.12],0.7465152854323911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27271,171,0.94 [0.73-1.21],0.6463375977595638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25844,129,0.79 [0.59-1.07],0.1297237790321166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26178,104,0.92 [0.67-1.27],0.6074373726009301
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27279,331,0.80 [0.66-0.96],0.0191977403280246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27198,250,0.81 [0.65-1.01],0.0606246786846467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27266,247,0.94 [0.76-1.17],0.5928044893301048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27256,237,0.95 [0.76-1.18],0.6223644507628983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",26975,42,1.23 [0.78-1.94],0.380828818221026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24379,640,0.92 [0.81-1.05],0.2151786390454996
